The change could affect thousands of patients so here's a breakdown of what we know, and what it means for you
Initially, Pfizer and the other companies tried to keep it to a medical indication, meaning this was really for people who had diabetic issues or atherosclerosis, blood flow issues, Caplan says

Below are symptoms that occur with those diagnoses: Major Depressive Disorder Feeling sad, empty or hopeless Not feeling interested in or enjoying things that you used to like Difficulty concentrating on everyday tasks Low self-esteem or excessive guilt about things Pessimism about the future Thoughts about death Insomnia or oversleeping Overeating or undereating, which can lead to weight changes A constant feeling of fatigue Generalized Anxiety Disorder Unexplained fear or excessive worry Agitation or restlessness Irritability or becoming easily annoyed Issues falling or staying asleep Brain fog or difficulty thinking clearly Lexapro can also be used off-label (not approved by the FDA) for other mental health diagnoses including obsessive-compulsive disorder, post traumatic stress disorder, panic disorder, social anxiety disorder and some eating disorders

One thing to consider is that most insurance plans do not cover GLP-1 medications for weight loss, and these medications can be very expensive
To better understand the association between eryptosis and inflammation in PD patients, the same group investigated eryptosis in PD-related peritonitis, the most common complication in patients treated by PD
Wellbutrin can provide additional energy and concentration benefits that complement the mood-stabilizing effects of Zoloft